Compound Medications
Mfg : StriveMens Hair TriGro
Triple-Component Formulation: Combines Finasteride, Minoxidil, and Biotin in one daily capsule.
DHT Pathway Support: Contains Finasteride to inhibit 5α-reductase enzyme activity.
Circulation Support: Includes Minoxidil to support blood flow to hair follicles.
Nutritional Foundation: Provides Biotin to support keratin production and hair structure.
Multi-Targeted Approach: Addresses multiple biological pathways involved in hair health.
Medical Supervision: Requires prescription and ongoing healthcare provider oversight.
Disclaimer: The FDA may not have evaluated this product for safety, effectiveness, or quality.Maximum Doses: 4
Per Dose $ 00.00
Total Price
TriGroRx is a prescription-only oral supplement formulated for men experiencing male pattern hair loss. It combines three active components that work through different biological pathways. This medication requires proper medical evaluation and supervision to ensure appropriate use and monitoring.
The TriGroRx formula contains Finasteride, which works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT). It also includes Minoxidil, a vasodilator that may improve blood flow to hair follicles, and Biotin, a B-vitamin that serves as a nutritional support element for hair structure.
This formulation takes a comprehensive approach by addressing multiple aspects of hair biology. The combination includes a DHT inhibitor, a circulation-supporting component, and essential nutritional support. This multi-targeted strategy is designed to provide a more complete approach to hair management than single-ingredient formulations.
TriGroRx is typically administered as one oral capsule daily. Consistent use as directed by a healthcare provider is important for maintaining steady levels of the active ingredients. Patients should follow their physicians instructions precisely and attend all recommended follow-up appointments.
This medication requires a prescription and medical supervision. Potential side effects and drug interactions should be discussed with a healthcare provider. Regular monitoring may be necessary during treatment. Patients should disclose their full medical history and current medications before beginning treatment.
